reports
UroGen Pharma Announces Commencement of Public Offering of Ordinary Sh...
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants PRINCETON, N.J., June 17, 2024 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell its ordinary shares and pre-funded warrants. In connection with the proposed offering, UroGen also expects to grant the underwriters a 30-day option to p...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
ROL ROLLINS INC.
PSIX POWER SOLUTIONS INTERNATIONAL INC.
OLLI OLLIE'S BARGAIN OUTLET HOLDINGS INC
LMAT LEMAITRE VASCULAR INC.
IRT INDEPENDENCE REALTY TRUST INC.
HAS HASBRO INC.
ESS ESSEX PROPERTY TRUST INC.
CDNS CADENCE DESIGN SYSTEMS INC.
ADBE ADOBE INC.
NFLX NETFLIX INC.
TTC TORO COMPANY
USM UNITED STATES CELLULAR CORP
USLM U.S. LIME & MINERALS
URGN UROGEN PHARMA
AVGO BROADCOM INC.
SPOT SPOTIFY TECHNOLOGY SA
FRHC FREEDOM HOLDING CORP
DCTH DELCATH SYSTEMS
TERN TERNS PHARMACEUTICALS
SMMT SUMMIT THERAPEUTICS INC
MEG MONTROSE ENVIRONMENTAL GROUP
ALHC ALIGNMENT HEALTHCARE INC
MITT AG MORTGAGE INVESTMENT TRUST INC
APP APPLOVIN CORP
ASTS AST SPACEMOBILE INC
NU NU HLDGS LTD
BRCC BRC INC
NGNE NEUROGENE INC
AKA AKA BRANDS HOLDING CORP
INST INSTRUCTURE HLDGS INC
SYRS SYROS PHARMACEUTICALS INC.
AUID AUTHID INC
NLCP NEWLAKE CAPITAL PARTNERS INC COM
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
WLDN WILLDAN GROUP
TDS TELEPHONE AND DATA SYSTEMS INC.
OSUR ORASURE TECHNOLOGIES INC.
ICFI ICF INTERNATIONAL INC.
BGS B&G FOODS INC.
BCRX BIOCRYST PHARMACEUTICALS INC.
QUAD QUAD/GRAPHICS INC. CLASS A
GTN GRAY TELEVISION INC.
USM UNITED STATES CELLULAR CORP
INFU INFUSYSTEMS HOLDINGS INC.
IRTC IRHYTHM TECHNOLOGIES INC.
URGN UROGEN PHARMA
DESP DESPEGAR.COM CORP.
BKNG BOOKING HOLDINGS INC.
ALEC ALECTOR
PGNY PROGYNY
ACEL ACCEL ENTERTAINMENT (A)
PRDO PERDOCEO EDUCATION CORP
LSEA LANDSEA HOMES CORP (A)
DFH DREAM FINDERS HOMES
PHVS PHARVARIS NV
DKNG AMGEN INC
GLSI DRAFTKINGS INC.
GREENWICH LIFESCIENCES INC
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
BAH, HURN, NOTV, PAGS, SPOK, ROKU, BZH, HOV, MTH, SKX, SAM, DESP, BJRI, RKLB, IONQ, KLAC, INTC, CNX, CLB, CRK, OVV, SOFI, TROW, AX, CINF, DLR, ABR, RWT, BFST, INBK, AUPH, BBIO, DSGN, RPHM, URGN, RCEL, AXNX, CUTR, PLSE, In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patte...
MTH MERITAGE HOMES CORPORATION
HURN HURON CONSULTING GROUP INC.
CUTR CUTERA INC.
BZH BEAZER HOMES USA INC.
BAH BOOZ ALLEN HAMILTON HOLDING CORPORATION CLASS A
BJRI BJ'S RESTAURANTS INC.
AUP AURINIA PHARMACEUTICALS INC.
SAM BOSTON BEER COMPANY INC. CLASS A
SPOK SPOK HOLDINGS
PLSE PULSE BIOSCIENCES
URGN UROGEN PHARMA
ROKU ROKU INC. CLASS A
DESP DESPEGAR.COM CORP.
PAGS PAGSEGURO DIGITAL LTD
HOV HOVNANIAN ENTERPRISES INC. CLASS A
BBIO BRIDGEBIO PHARMA
NOTV INOTIV INC
DSGN DESIGN THERAPEUTICS INC
RPHM RENEO PHARMACEUTICALS INC
RKLB ROCKET LAB USA INC
RCEL AVITA MEDICAL INC
AKNX TEKHNOLOGII 100
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
n this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
EME EMCOR GROUP
CMCSA COMCAST CORPORATION CLASS A
LII LENNOX INTERNATIONAL INC.
WDC WESTERN DIGITAL CORPORATION
VNO VORNADO REALTY TRUST
TXT TEXTRON INC.
PNR PENTAIR PLC
ORRF ORRSTOWN FINANCIAL SERVICES INC.
ON ON SEMICONDUCTOR CORPORATION
NYCB NEW YORK COMMUNITY BANCORP INC.
FORM FORMFACTOR INC.
CRS CARPENTER TECHNOLOGY CORPORATION
AR ANTERO RESOURCES CORPORATION
AMSC AMERICAN SUPERCONDUCTOR CORP.
AEIS ADVANCED ENERGY INDUSTRIES INC.
QUAD QUAD/GRAPHICS INC. CLASS A
JOE ST. JOE COMPANY
CCL CARNIVAL CORPORATION
HLX HELIX ENERGY SOLUTIONS GROUP INC.
HP HELMERICH & PAYNE INC.
VSTO VISTA OUTDOOR INC
BF.A BROWN-FORMAN CORP. CL A
ITGR INTEGER HOLDINGS CORPORATION
USAP UNIVERSAL STAINLESS & ALLOY PRODUCTS INC.
URGN UROGEN PHARMA
EOLS EVOLUS INC
CMPR CIMPRESS PLC
CARR CARRIER GLOBAL CORP.
TARS TARSUS PHARMACEUTICALS
OS OFFICINA STELLARE
TCBX THIRD COAST BANCSHARES INC
FAF FIRE & FLOWERS HLDGS CORP
N INCO LTD.
- Jonathan Moreland
HZN HORIZON GLOBAL CORP.
FFIN FIRST FINANCIAL BANKSHARES INC
CUTR CUTERA INC.
NCBS NICOLET BANKSHARES INC
NAUT NAUTILUS MARINE SERVICES
KBR KBR INC.
IROQ IF BANCORP INC
CTHR CHARLES & COLVARD LTD.
MRSN MERSANA THERAPEUTICS
URGN UROGEN PHARMA
PETQ PETIQ INC. CLASS A
FRPT FORCE PROTECTION
BHC INC.
ELAN BAUSCH HEALTH COMPANIES INC.
KFS ELANCO ANIMAL HEALTH INC.
OTLK KINGSWAY FINANCIAL SERVICES
BRBR OUTLOOK THERAPEUTICS
AHCO BELLRING BRANDS
AESE ADAPTHEALTH
RC ALLIED ESPORTS ENTERTAINMENT
HGBL GRUPO RADIO CENTRO S.A.B. DE C.V.
PSTX HERITAGE GLOBAL
HPK POSEIDA THERAPEUTICS
OLMA INC.
OEG HIGHPEAK ENERGY INC (A)
BVH OLEMA PHARMACEUTICALS
FLUX ORBITAL ENERGY GROUP
TPGY BLUEGREEN VACATIONS HOLDING CORPORATION (A)
CYTH FLUX POWER HOLDINGS
CNTA TPG PACE BENEFICIAL FINANCE
NSPR CYCLO THERAPEUTICS
STGW CENTESSA PHARMACEUTICALS PLC
INSPIREMD INC
STAGWELL INC
Urogen Pharma Ltd: 2 directors
Two Directors at Urogen Pharma Ltd bought/maiden bought 5,000 shares at between 15.710USD and 15.850USD. The significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's di...
- Dave Nicoski
- Ross LaDuke
TXMD THERAPEUTICSMD INC.
TSN TYSON FOODS INC. CLASS A
PPC PILGRIM'S PRIDE CORPORATION
PBYI PUMA BIOTECHNOLOGY INC.
LOPE GRAND CANYON EDUCATION INC.
HBI HANESBRANDS INC.
GD GENERAL DYNAMICS CORPORATION
FARM FARMER BROS. CO.
ENTA ENANTA PHARMACEUTICALS INC.
CLVS CLOVIS ONCOLOGY INC.
CLR CONTINENTAL RESOURCES INC.
ASC ARDMORE SHIPPING
ACRX ACELRX PHARMACEUTICALS
ABEO ABEONA THERAPEUTICS INC.
QUAD QUAD/GRAPHICS INC. CLASS A
HFC HOLLYFRONTIER CORPORATION
KEX KIRBY CORPORATION
TRC TEJON RANCH CO.
JBSS JOHN B. SANFILIPPO & SON INC.
INGR-R-A INGRA D.D.
URGN UROGEN PHARMA
TYME TYME TECHNOLOGIES
XFOR X4 PHARMACEUTICALS INC
APLT APPLIED THERAPEUTICS
TH TARGET HOSPITALITY CORP (A)
OYST OYSTER POINT PHARMA
SOLY SOLITON INC
RTX RAYTHEON TECHNOLOGIES CORPORATION
DSS DOCUMENT SECURITY SYSTEMS
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
XONE EXONE CO
VKTX VIKING THERAPEUTICS
VIVO MERIDIAN BIOSCIENCE INC.
SMED SHARPS COMPLIANCE
SM SM ENERGY COMPANY
QADA QAD CLASS A
PERI PERION NETWORK LTD
ENLV ENLIVEX THERAPEUTICS
NK NANTKWEST
KRNT KORNIT DIGITAL LTD.
ICAD ICAD INC.
FCX FREEPORT-MCMORAN INC.
DRNA DICERNA PHARMACEUTICALS
DDD 3D SYSTEMS CORPORATION
CPST CAPSTONE TURBINE CORP.
CLVS CLOVIS ONCOLOGY INC.
ARWR ARROWHEAD PHARMACEUTICALS INC.
APPS DIGITAL TURBINE
ATKR ATKORE INC
ZIXI ZIX CORP.
MSON MISONIX INC.
AP AMPCO-PITTSBURGH
PLSE PULSE BIOSCIENCES
FLGT FULGENT GENETICS
PUMP PROPETRO HOLDING CORP.
VREX VAREX IMAGING CORPORATION
EXPI EXP WORLD HOLDINGS
URGN UROGEN PHARMA
RFL RAFAEL HOLDINGS CL B
FLNT FLUENT INC
STIM NEURONETICS
INS INSTONE REAL ESTATE GROUP AG
TBIO TRANSLATE BIO
ORGO ORGANOGENESIS HOLDINGS (A)
DT DYNATRACE INC.
AXLA AXCELLA HEALTH
SWTX SPRINGWORKS THERAPEUTICS
OCGN OCUGEN INC
XGN EXAGEN
DMTK DERMTECH INC
RVMD REVOLUTION MEDICINES
VRM VROOM
CPE CALLON PETROLEUM
BILL BILL.COM HOLDINGS
BEAM BEAM THERAPEUTICS
AMTI APPLIED MOLECULAR TRANSPORT
DNMR DANIMER SCIENTIFIC
PUBM INC.
RUBY PUBMATIC
RBC U.S. BANKS YIELD INDEX ETF
- Dave Nicoski
- Ross LaDuke
OXY OCCIDENTAL PETROLEUM CORPORATION
USB U.S. BANCORP
C CITIGROUP INC.
SRDX SURMODICS INC.
RYAM RAYONIER ADVANCED MATERIALS INC
NVTA INVITAE CORP
NUS NU SKIN ENTERPRISES INC. CLASS A
NKTR NEKTAR THERAPEUTICS
GPS GAP INC.
GDOT GREEN DOT CORPORATION CLASS A
FPRX FIVE PRIME THERAPEUTICS INC.
FOXF FOX FACTORY HOLDING CORP.
FITB FIFTH THIRD BANCORP
FCX FREEPORT-MCMORAN INC.
EZPW EZCORP INC. CLASS A
EIGI ENDURANCE INTERNATIONAL GROUP HOLDINGS INC.
EDIT EDITAS MEDICINE INC.
DY DYCOM INDUSTRIES INC.
DVAX DYNAVAX TECHNOLOGIES CORPORATION
CFG CITIZENS FINANCIAL GROUP INC.
BOX BOX INC. CLASS A
AMG AFFILIATED MANAGERS GROUP INC.
AGIO AGIOS PHARMACEUTICALS INC.
AFMD AFFIMED N.V.
AEO AMERICAN EAGLE OUTFITTERS INC.
AAP ADVANCE AUTO PARTS INC.
FLR FLUOR CORPORATION
ARCB ARCBEST CORPORATION
ATRO ASTRONICS CORPORATION
CENX CENTURY ALUMINUM COMPANY
FSLR FIRST SOLAR INC.
GIII G-III APPAREL GROUP LTD.
MPX MARINE PRODUCTS CORP.
SCVL SHOE CARNIVAL INC.
CC CHEMOURS CO.
FBK FB FINANCIAL CORPORATION
AA ALCOA CORPORATION
HOME AT HOME GROUP INC.
ANAB ANAPTYSBIO INC.
URGN UROGEN PHARMA
CATC CAMBRIDGE BANCORP
OPTN OPTINOSE
DSKE DASEKE
UBX UNITY BIOTECHNOLOGY
FOCS FOCUS FINANCIAL PARTNERS
UPWK UPWORK
CYCN CYCLERION THERAPEUTICS
DELL DELL TECHNOLOGIES INC CLASS C
HCAT HEALTH CATALYST
REZI RESIDEO TECHNOLOGIES INC.
CRMD CORMEDIX INC.
- Jonathan Moreland
LNG CHENIERE ENERGY INC.
VVI VIAD CORP
VIVO MERIDIAN BIOSCIENCE INC.
TNAV TELENAV
SFNC SIMMONS FIRST NATIONAL CORPORATION CLASS A
RYAM RAYONIER ADVANCED MATERIALS INC
PRTY PARTY CITY HOLDCO INC.
PFLT PENNANTPARK FLOATING RATE CAPITAL LTD.
OPK OPKO HEALTH INC.
NGL NGL ENERGY PARTNERS LP
MTDR MATADOR RESOURCES COMPANY
MCD MCDONALD'S CORPORATION
JRVR JAMES RIVER GROUP HOLDINGS LTD
GVA GRANITE CONSTRUCTION INCORPORATED
ESPR ESPERION THERAPEUTICS INC.
AKBA AKEBIA THERAPEUTICS INC.
AGIO AGIOS PHARMACEUTICALS INC.
UVE UNIVERSAL INSURANCE HOLDINGS INC.
MTNB MATINAS BIOPHARMA HOLDINGS INC
SAFE SAFESTORE HOLDINGS PLC
CNFR CONIFER HOLDINGS
ET ENERGY TRANSFER L.P.
FET FORUM ENERGY TECHNOLOGIES INC.
PAGP PLAINS GP HOLDINGS LP CLASS A
TDC TERADATA CORPORATION
FLXS FLEXSTEEL INDUSTRIES INC.
BXC BLUELINX HOLDINGS
NBLX NOBLE MIDSTREAM PARTNERS LP
CDEV CENTENNIAL RESOURCE DEVELOPMENT INC. CLASS A
ATGE ADTALEM GLOBAL EDUCATION INC.
XM91 SMTC CORP.
URGN UROGEN PHARMA
ANGI ANGI INC. CLASS A
TURN 180 DEGREE CAPITAL
HOG HARLEY-DAVIDSON INC.
STKL SUNOPTA
SMPL INC.
MVBF SIMPLY GOOD FOODS CO
PED MVB FINANCIAL CORP
TORC PEDEVCO CORP
CLNC RESTORBIO INC
AMEH COLONY CREDIT REAL ESTATE (A)
ZVO APOLLO MEDICAL HOLDINGS INC
MEC ZOVIO INC
APRN MAYVILLE ENGINEERING
WORK BLUE APRON HOLDINGS
CTVA SLACK TECHNOLOGIES
ANDE INC.
GCI CORTEVA
OXLC INC.
THE ANDERSONS
INC.
GANNETT CO. INC.
OXFORD LANE CAPITAL CORP.
- Jonathan Moreland
HZN HORIZON GLOBAL CORP.
CALA CALITHERA BIOSCIENCES INC.
ARMK ARAMARK
AKBA AKEBIA THERAPEUTICS INC.
ACY AEROCENTURY
KMI KINDER MORGAN INC CLASS P
ADES ADVANCED EMISSIONS SOLUTIONS
MYOV MYOVANT SCIENCE
EXPI EXP WORLD HOLDINGS
URGN UROGEN PHARMA
MVBF MVB FINANCIAL CORP
OFG ORIENTAL FINANCIAL GROUP
AMEH INC.
WORK APOLLO MEDICAL HOLDINGS INC
SLACK TECHNOLOGIES
INC.
- Jonathan Moreland
SIX SIX FLAGS ENTERTAINMENT CORPORATION
LNG CHENIERE ENERGY INC.
TNAV TELENAV
SYNL SYNALLOY CORP.
SIGI SELECTIVE INSURANCE GROUP INC.
RLH RED LION HOTELS
PBF PBF ENERGY INC. CLASS A
NGL NGL ENERGY PARTNERS LP
MCD MCDONALD'S CORPORATION
LMNX LUMINEX CORP
IMMR IMMERSION CORP.
HZN HORIZON GLOBAL CORP.
GVA GRANITE CONSTRUCTION INCORPORATED
GLPI GAMING AND LEISURE PROPERTIES INC.
GABC GERMAN AMERICAN BANCORP
CALA CALITHERA BIOSCIENCES INC.
BCRX BIOCRYST PHARMACEUTICALS INC.
ATEN A10 NETWORKS INC.
ARMK ARAMARK
AKBA AKEBIA THERAPEUTICS INC.
AGRX AGILE THERAPEUTICS
UVE UNIVERSAL INSURANCE HOLDINGS INC.
ENPH ENPHASE ENERGY INC.
KMI KINDER MORGAN INC CLASS P
MGM MGM RESORTS INTERNATIONAL
PAGP PLAINS GP HOLDINGS LP CLASS A
KDMN KADMON HOLDINGS
CNBKA CENTURY BANCORP INC. CL A
GIFI GULF ISLAND FABRICATION INC.
NBLX NOBLE MIDSTREAM PARTNERS LP
CDEV CENTENNIAL RESOURCE DEVELOPMENT INC. CLASS A
ADES ADVANCED EMISSIONS SOLUTIONS
VERI VERITONE INC.
ATGE ADTALEM GLOBAL EDUCATION INC.
XM91 SMTC CORP.
MYOV MYOVANT SCIENCE
URGN UROGEN PHARMA
MVBF MVB FINANCIAL CORP
PED PEDEVCO CORP
OFG ORIENTAL FINANCIAL GROUP
KDP INC.
REPL KEURIG DR PEPPER INC.
UPWK REPLIMUNE GROUP
REZI UPWORK
AMEH RESIDEO TECHNOLOGIES
HHC INC.
FSK APOLLO MEDICAL HOLDINGS INC
ZM THE HOWARD HUGHES CORPORATION
NXTC FS KKR CAPITAL CORP
PPR ZOOM VIDEO COMMUNICATIONS
CTVA INC.
ET NEXTCURE
AVDL ING PRIME RATE TRUST
GCI CORTEVA
INC.
EXACTTARGET INC.
AVONDALE INDUSTRIES INC.
GANNETT CO. INC.
UroGen Pharma Reports Second Quarter 2018 Financial Results and Recent...
UroGen Pharma Reports Second Quarter 2018 Financial Results and Recent Corporate Developments Plan to Initiate Q4 2018 Rolling New Drug Application (NDA) Submission to the U.S. Food and Drug Administration (FDA) for UGN-101, Ahead of Initial Projection of Q1 2019 Initiated Phase 2b Clinical Trial of UGN-102 (VesiGel™) for the Treatment of Low-Grade Non-Muscle Invasive Bladder Cancer (LG NMIBC) Conference Call Today at 8:30 a.m. Eastern Time RA’ANANA, Israel and NEW YORK, Aug. 14, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company de...
UroGen Pharma Appoints Peter P. Pfreundschuh as Chief Financial Office...
UroGen Pharma Appoints Peter P. Pfreundschuh as Chief Financial Officer Life Sciences Veteran Brings Extensive Global Finance, Commercial Operations and Business Development Experience to Prepare UroGen for its Transition from a Clinical Stage Company to Commercialization RA’ANANA, Israel, and NEW YORK, Aug. 08, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company today announced that Peter P. Pfreundschuh has been appointed as Chief Financial Officer (CFO) effective August 20, 2018. Mr. Pfreundschuh brings to UroGen more than two decades...
UroGen Pharma to Report Second Quarter 2018 Financial Results on Tuesd...
UroGen Pharma to Report Second Quarter 2018 Financial Results on Tuesday, August 14, 2018 Conference Call and Webcast Scheduled for 8:30 AM ET RA’ANANA, Israel and NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ:URGN) today announced that it will report second quarter 2018 financial results on Tuesday, August 14, 2018, prior to the open of the market. The announcement will be followed by a live audio webcast and conference call at 8:30AM Eastern Time. Audio Webcast The webcast will be made available on the Investors section of the Company’s website at . Followin...
UroGen Pharma Submits Investigational New Drug (IND) Application for U...
UroGen Pharma Submits Investigational New Drug (IND) Application for UGN-102 (VesiGel™) for the Treatment of Low-Grade Non-Muscle Invasive Bladder Cancer (LG NMIBC) Company Expects to Begin U.S. Phase 2b Clinical Trial in Q3 2018 UGN-102 Has Potential to Become the First Front Line Non-Surgical Therapy for Patients with LG NMIBC RA’ANANA, Israel and NEW YORK, July 11, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on uro-oncology, today announced that...
UroGen Pharma Appoints Shawn Cline Tomasello to its Board of Directors...
UroGen Pharma Appoints Shawn Cline Tomasello to its Board of Directors Tomasello is a Renowned Industry Expert Responsible for the Commercialization of Revolutionary, Multi-Billion Dollar Products in Hematology-Oncology RA’ANANA, Israel and NEW YORK, July 10, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on uro-oncology, today announced that Shawn Cline Tomasello has been appointed to its Board of Directors. Ms. Tomasello is an industry expert who m...
UroGen Pharma’s Chairman, Arie Belldegrun, MD, FACS to Receive EY 20...
UroGen Pharma’s Chairman, Arie Belldegrun, MD, FACS to Receive EY 2018 Master Entrepreneur Award RA’ANANA, Israel and NEW YORK, June 13, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on uro-oncology, today announced that Arie Belldegrun, MD, FACS, UroGen’s Chairman, will be honored with the prestigious EY Master Entrepreneur Award during the Entrepreneur of the Year 2018 Awards Gala on Thursday, June 14, 2018 in Los Angeles. The Master Entrepreneur Aw...
UroGen Pharma Announces Stephen Mullennix as Interim Chief Financial O...
UroGen Pharma Announces Stephen Mullennix as Interim Chief Financial Officer and Jason Patel as Vice President of Finance RA’ANANA, Israel, and NEW YORK, June 05, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, today announced that Stephen Mullennix, UroGen’s Chief Operating Officer, will become Interim Chief Financial Officer, replacing Gary Titus. Mr. Titus will remain as a consultant during the transition. “Gary played an important role in the early stages of bui...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.